IUCRO-0049; Immunological Genetic Molecular and pathological Correlates with Clinical and Treatment Outcome in Patients With Renal Cell Carcinoma

T
Theodore Logan, MD

Primary Investigator

Overview

The major purposes of this research study is to obtain blood and tissue samples from patients diagnosed with kidney cancer and/or tissue samples from patients undergoing surgery for their kidney cancer and to obtain clinical information.

Description

The major purposes of this research study is to obtain blood and tissue samples from patients diagnosed with kidney cancer and/or tissue samples from patients undergoing surgery for their kidney cancer and to obtain clinical information.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Renal Cell Carcinoma
  • Age: Between 18 Years - 100 Years
  • Gender: All

Inclusion Criteria
Patients must have documented or suspected renal cell cancer.
Additional Information:
Participants will not be paid for their participation.

Updated on 23 Apr 2024. Study ID: 1011004244 (0311-39)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center